{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:44:26Z","timestamp":1792626266817,"version":"4.5.0"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s12016-019-08755-8","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T17:02:27Z","timestamp":1562086947000},"page":"273-297","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":115,"title":["The Relationship Between Hypermobile Ehlers-Danlos Syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), and Mast Cell Activation Syndrome (MCAS)"],"prefix":"10.1007","volume":"58","author":[{"given":"Alison Haley","family":"Kucharik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4397-5217","authenticated-orcid":false,"given":"Christopher","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,2]]},"reference":[{"key":"8755_CR1","doi-asserted-by":"crossref","unstructured":"Beighton P, Grahame R, Bird H (2012) Introduction to hypermobility. In: Hypermobility of joints. Springer, p 1","DOI":"10.1007\/978-1-84882-085-2"},{"issue":"1","key":"8755_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1365-2141.2008.06994.x","volume":"141","author":"LA Parapia","year":"2008","unstructured":"Parapia LA, Jackson C (2008) Ehlers-Danlos syndrome \u2013 a historical review. Br J Haematol. 141(1):32\u201335","journal-title":"Br J Haematol."},{"issue":"1","key":"8755_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.0.CO;2-O","volume":"77","author":"P Beighton","year":"1999","unstructured":"Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ (1999) Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Am J Med Genet. 77(1):31\u201337","journal-title":"Am J Med Genet."},{"issue":"1","key":"8755_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ajmg.c.31552","volume":"175","author":"F Malfait","year":"2017","unstructured":"Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J et al (2017) The 2017 International Classification of the Ehlers\u2013Danlos syndromes. Am J Med Genet C Semin Med Genet. 175(1):8\u201326","journal-title":"Am J Med Genet C Semin Med Genet."},{"key":"8755_CR5","doi-asserted-by":"crossref","unstructured":"Steinmann B, Royce PM, Superti-Furga A (2003) The Ehlers-Danlos syndrome. In: Connective tissue and its heritable disorders. Wiley-Blackwell, pp 431\u2013523","DOI":"10.1002\/0471221929.ch9"},{"issue":"1","key":"8755_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ajmg.c.31538","volume":"175","author":"B Tinkle","year":"2017","unstructured":"Tinkle B, Castori M, Berglund B, Cohen H, Grahame R, Kazkaz H et al (2017) Hypermobile Ehlers\u2013Danlos syndrome (a.k.a. Ehlers\u2013Danlos syndrome type III and Ehlers\u2013Danlos syndrome hypermobility type): clinical description and natural history. Am J Med Genet C Semin Med Genet. 175(1):48\u201369","journal-title":"Am J Med Genet C Semin Med Genet."},{"issue":"1","key":"8755_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1399-0004.2012.01858.x","volume":"82","author":"A De Paepe","year":"2012","unstructured":"De Paepe A, Malfait F (2012) The Ehlers\u2013Danlos syndrome, a disorder with many faces. Clin Genet. 82(1):1\u201311","journal-title":"Clin Genet."},{"issue":"9","key":"8755_CR8","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1002\/ajmg.a.33585","volume":"152A","author":"M Castori","year":"2010","unstructured":"Castori M, Camerota F, Celletti C, Grammatico P, Padua L (2010) Ehlers-Danlos syndrome hypermobility type and the excess of affected females: possible mechanisms and perspectives. Am J Med Genet A. 152A(9):2406\u20132408","journal-title":"Am J Med Genet A."},{"key":"8755_CR9","volume-title":"GeneReviews","author":"HP Levy","year":"2018","unstructured":"Levy HP (2018) Ehlers-Danlos syndrome, hypermobility type. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Stephens K et al (eds) GeneReviews. University of Washington, Seattle, Seattle"},{"issue":"1","key":"8755_CR10","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1086\/376564","volume":"73","author":"MC Zweers","year":"2003","unstructured":"Zweers MC, Bristow J, Steijlen PM, Dean WB, Hamel BC, Otero M et al (2003) Haploinsufficiency of TNXB is associated with hypermobility type of Ehlers-Danlos syndrome. Am J Hum Genet. 73(1):214\u2013217","journal-title":"Am J Hum Genet."},{"issue":"8","key":"8755_CR11","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1210\/jc.2015-2232","volume":"100","author":"R Morissette","year":"2015","unstructured":"Morissette R, Chen W, Perritt AF, Dreiling JL, Arai AE, Sachdev V et al (2015) Broadening the spectrum of Ehlers Danlos syndrome in patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 100(8):1143","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"8755_CR12","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1093\/hmg\/3.9.1617","volume":"3","author":"P Narcisi","year":"1994","unstructured":"Narcisi P, Richards AJ, Ferguson SD, Pope FM (1994) A family with Ehlers-Danlos syndrome type III\/articular hypermobility syndrome has a glycine 637 to serine substitution in type III collagen. Hum Mol Genet. 3(9):1617\u20131620","journal-title":"Hum Mol Genet."},{"key":"8755_CR13","doi-asserted-by":"publisher","first-page":"e828970","DOI":"10.1155\/2015\/828970","volume":"2015","author":"D Syx","year":"2015","unstructured":"Syx D, Symoens S, Steyaert W, De Paepe A, Coucke PJ, Malfait F (2015) Ehlers-Danlos syndrome, hypermobility type, is linked to chromosome 8p22-8p21.1 in an extended Belgian family. Dis Markers 2015:e828970","journal-title":"Dis Markers"},{"issue":"3","key":"8755_CR14","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/ajmg.a.33231","volume":"152A","author":"M Castori","year":"2010","unstructured":"Castori M, Camerota F, Celletti C, Danese C, Santilli V, Saraceni VM et al (2010) Natural history and manifestations of the hypermobility type Ehlers-Danlos syndrome: a pilot study on 21 patients. Am J Med Genet A. 152A(3):556\u2013564","journal-title":"Am J Med Genet A."},{"issue":"1","key":"8755_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ajmg.c.31425","volume":"169C","author":"M Castori","year":"2015","unstructured":"Castori M, Dordoni C, Morlino S, Sperduti I, Ritelli M, Valiante M et al (2015) Spectrum of mucocutaneous manifestations in 277 patients with joint hypermobility syndrome\/Ehlers-Danlos syndrome, hypermobility type. Am J Med Genet C Semin Med Genet. 169C(1):43\u201353","journal-title":"Am J Med Genet C Semin Med Genet."},{"issue":"12","key":"8755_CR16","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1002\/ajmg.a.36315","volume":"161","author":"M Castori","year":"2013","unstructured":"Castori M, Morlino S, Celletti C, Ghibellini G, Bruschini M, Grammatico P et al (2013) Re-writing the natural history of pain and related symptoms in the joint hypermobility syndrome\/Ehlers\u2013Danlos syndrome, hypermobility type. Am J Med Genet A. 161(12):2989\u20133004","journal-title":"Am J Med Genet A."},{"issue":"6","key":"8755_CR17","first-page":"998","volume":"29","author":"M Castori","year":"2011","unstructured":"Castori M, Sperduti I, Celletti C, Camerota F, Grammatico P (2011) Symptom and joint mobility progression in the joint hypermobility syndrome (Ehlers-Danlos syndrome, hypermobility type). Clin Exp Rheumatol. 29(6):998\u20131005","journal-title":"Clin Exp Rheumatol."},{"issue":"3","key":"8755_CR18","first-page":"597","volume":"29","author":"M Castori","year":"2011","unstructured":"Castori M, Celletti C, Camerota F, Grammatico P (2011) Chronic fatigue syndrome is commonly diagnosed in patients with Ehlers-Danlos syndrome hypermobility type\/joint hypermobility syndrome. Clin Exp Rheumatol. 29(3):597\u2013598","journal-title":"Clin Exp Rheumatol."},{"issue":"6","key":"8755_CR19","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.ijnurstu.2010.10.007","volume":"48","author":"S Maeland","year":"2011","unstructured":"Maeland S, Assmus J, Berglund B (2011) Subjective health complaints in individuals with Ehlers-Danlos syndrome: a questionnaire study. Int J Nurs Stud. 48(6):720\u2013724","journal-title":"Int J Nurs Stud."},{"issue":"1","key":"8755_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ajmg.c.31546","volume":"175","author":"A Fikree","year":"2017","unstructured":"Fikree A, Chelimsky G, Collins H, Kovacic K, Aziz Q (2017) Gastrointestinal involvement in the Ehlers\u2013Danlos syndromes. Am J Med Genet C Semin Med Genet. 175(1):181\u2013187","journal-title":"Am J Med Genet C Semin Med Genet."},{"issue":"1","key":"8755_CR21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/ajmg.c.31539","volume":"175","author":"M Castori","year":"2017","unstructured":"Castori M, Tinkle B, Levy H, Grahame R, Malfait F, Hakim A (2017) A framework for the classification of joint hypermobility and related conditions. Am J Med Genet C Semin Med Genet. 175(1):148\u2013157","journal-title":"Am J Med Genet C Semin Med Genet."},{"issue":"5","key":"8755_CR22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1136\/ard.32.5.413","volume":"32","author":"P Beighton","year":"1973","unstructured":"Beighton P, Solomon L, Soskolne C (1973) Articular mobility in an African population. Ann Rheum Dis. 32(5):413\u2013418","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"8755_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/ajmg.c.31540","volume":"175","author":"B Juul-Kristensen","year":"2017","unstructured":"Juul-Kristensen B, Schmedling K, Rombaut L, Lurd H, Engelbert RHH (2017) Measurement properties of clinical assessment methods for classifying generalized joint hypermobility\u2014a systematic review. Am J Med Genet C Semin Med Genet. 175(1):116\u2013147","journal-title":"Am J Med Genet C Semin Med Genet."},{"issue":"3","key":"8755_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1742-1241.2003.tb10455.x","volume":"57","author":"AJ Hakim","year":"2003","unstructured":"Hakim AJ, Grahame R (2003) A simple questionnaire to detect hypermobility: an adjunct to the assessment of patients with diffuse musculoskeletal pain. Int J Clin Pract. 57(3):163\u2013166","journal-title":"Int J Clin Pract."},{"issue":"1","key":"8755_CR25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/ajmg.c.31554","volume":"175","author":"P Chopra","year":"2017","unstructured":"Chopra P, Tinkle B, Hamonet C, Brock I, Gompel A, Bulbena A et al (2017) Pain management in the Ehlers\u2013Danlos syndromes. Am J Med Genet C Semin Med Genet. 175(1):212\u2013219","journal-title":"Am J Med Genet C Semin Med Genet."},{"issue":"1","key":"8755_CR26","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ajmg.c.31543","volume":"175","author":"A Hakim","year":"2017","unstructured":"Hakim A, O\u2019Callaghan C, De Wandele I, Stiles L, Pocinki A, Rowe P (2017) Chronic fatigue in Ehlers\u2013Danlos syndrome\u2014hypermobile type. Am J Med Genet C Semin Med Genet. 175(1):168\u2013174","journal-title":"Am J Med Genet C Semin Med Genet."},{"issue":"1","key":"8755_CR27","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ajmg.c.31543","volume":"175","author":"A Hakim","year":"2017","unstructured":"Hakim A, O\u2019Callaghan C, De Wandele I, Stiles L, Pocinki A, Rowe P (2017) Cardiovascular autonomic dysfunction in Ehlers\u2013Danlos syndrome\u2014hypermobile type. Am J Med Genet C Semin Med Genet. 175(1):168\u2013174","journal-title":"Am J Med Genet C Semin Med Genet."},{"issue":"12","key":"8755_CR28","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1002\/ajmg.a.36060","volume":"161A","author":"T Bathen","year":"2013","unstructured":"Bathen T, H\u00e5ngmann AB, Hoff M, Andersen L\u00d8, Rand-Hendriksen S (2013) Multidisciplinary treatment of disability in Ehlers-Danlos syndrome hypermobility type\/hypermobility syndrome: a pilot study using a combination of physical and cognitive-behavioral therapy on 12 women. Am J Med Genet A. 161A(12):3005\u20133011","journal-title":"Am J Med Genet A."},{"issue":"2","key":"8755_CR29","first-page":"84","volume":"6","author":"SR Raj","year":"2006","unstructured":"Raj SR (2006) The postural tachycardia syndrome (POTS): pathophysiology, diagnosis & management. Indian Pacing Electrophysiol J. 6(2):84\u201399","journal-title":"Indian Pacing Electrophysiol J."},{"issue":"1 Part 1","key":"8755_CR30","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1212\/WNL.43.1_Part_1.132","volume":"43","author":"R Schondorf","year":"1993","unstructured":"Schondorf R, Low PA (1993) Idiopathic postural orthostatic tachycardia syndrome. Neurology 43(1 Part 1):132\u2013137","journal-title":"Neurology"},{"issue":"5","key":"8755_CR31","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/01.CIR.53.5.749","volume":"53","author":"CF Wooley","year":"1976","unstructured":"Wooley CF (1976) Where are the diseases of yesteryear? DaCosta\u2019s syndrome, soldiers heart, the effort syndrome, neurocirculatory asthenia--and the mitral valve prolapse syndrome. Circulation. 53(5):749\u2013751","journal-title":"Circulation."},{"issue":"5","key":"8755_CR32","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1542\/peds.2012-2610","volume":"131","author":"J Stewart","year":"2013","unstructured":"Stewart J (2013) Common syndromes of orthostatic intolerance. Pediatrics. 131(5):968\u2013980","journal-title":"Pediatrics."},{"key":"8755_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0002-9629(15)40480-X","volume":"319","author":"D Robertson","year":"1999","unstructured":"Robertson D (1999) The epidemic of orthostatic tachycardia and orthostatic hypotension. Am J Med Sci. 319:75\u201377","journal-title":"Am J Med Sci."},{"issue":"9","key":"8755_CR34","doi-asserted-by":"publisher","first-page":"753","DOI":"10.7326\/0003-4819-137-9-200211050-00011","volume":"137","author":"DS Goldstein","year":"2002","unstructured":"Goldstein DS, Robertson D, Esler M, Straus SE, Eisenhofer G (2002) Dysautonomias: clinical disorders of the autonomic nervous system. Ann Intern Med. 137(9):753\u2013763","journal-title":"Ann Intern Med."},{"key":"8755_CR35","unstructured":"Miller AJ, Raj SR. Pharmacotherapy for postural tachycardia syndrome. Auton Neurosci. 2018;S1566\u20130702(18):30025\u20130."},{"key":"8755_CR36","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1212\/01.wnl.0000267663.05398.40","volume":"69","author":"EM Garland","year":"2007","unstructured":"Garland EM, Raj SR, Black BK, Harris PA, Robertson D (2007) The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome. Neurology. 69:790\u2013798","journal-title":"Neurology."},{"issue":"3","key":"8755_CR37","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S0025-6196(11)61027-6","volume":"82","author":"M Thieben","year":"2007","unstructured":"Thieben M, Sandroni P, Sletten D, Benrud-Larson L, Fealey R, Vernino S et al (2007) Postural orthostatic tachycardia syndrome: the Mayo Clinic experience. Mayo Clin Proc. 82(3):308\u2013313","journal-title":"Mayo Clin Proc."},{"issue":"17","key":"8755_CR38","first-page":"30354","volume":"S1566\u20130702","author":"AC Arnold","year":"2018","unstructured":"Arnold AC, Ng J, Raj SR (2018) Postural tachycardia syndrome \u2013 diagnosis, physiology, and prognosis. Auton Neurosci. S1566\u20130702(17):30354\u201330355","journal-title":"Auton Neurosci."},{"issue":"5","key":"8755_CR39","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/j.1552-4604.1994.tb04977.x","volume":"34","author":"JJ Smith","year":"1994","unstructured":"Smith JJ, Porth CM, Erickson M (1994) Hemodynamic response to the upright posture. J Clin Pharmacol. 34(5):375\u2013386","journal-title":"J Clin Pharmacol."},{"issue":"23","key":"8755_CR40","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1161\/CIRCULATIONAHA.112.144501","volume":"127","author":"SR Raj","year":"2013","unstructured":"Raj SR (2013) Postural tachycardia syndrome (POTS). Circulation. 127(23):2336","journal-title":"Circulation."},{"issue":"20","key":"8755_CR41","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1161\/01.CIR.0000147280.90339.E9","volume":"110","author":"I Bonyhay","year":"2004","unstructured":"Bonyhay I, Freeman R (2004) Sympathetic nerve activity in response to hypotensive stress in the postural tachycardia syndrome. Circulation. 110(20):3193\u20133198","journal-title":"Circulation."},{"issue":"6","key":"8755_CR42","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/mus.24245","volume":"50","author":"C Haensch","year":"2014","unstructured":"Haensch C, Tosch M, Katona I, Weis J, Isenmann S (2014) Small-fiber neuropathy with cardiac denervation in postural tachycardia syndrome. Muscle Nerve. 50(6):956\u2013961","journal-title":"Muscle Nerve."},{"key":"8755_CR43","doi-asserted-by":"crossref","unstructured":"Jacob G, Costa F, Shannon JR, Robertson RM, Wathen M, Stein M et al (2000) The neuropathic postural tachycardia syndrome. N Eng J Med. 343(14):1008\u20131014","DOI":"10.1056\/NEJM200010053431404"},{"issue":"6","key":"8755_CR44","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1016\/j.hrthm.2015.03.029","volume":"12","author":"R Sheldon","year":"2015","unstructured":"Sheldon R, Grubb B, Olshansky B, Shen W, Calkins H, Brignole M et al (2015) 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 12(6):e63","journal-title":"Heart Rhythm."},{"issue":"8","key":"8755_CR45","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1056\/NEJM200002243420803","volume":"342","author":"JR Shannon","year":"2000","unstructured":"Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I et al (2000) Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med. 342(8):541\u2013549","journal-title":"N Engl J Med."},{"key":"8755_CR46","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1749-6632.2001.tb03703.x","volume":"940","author":"D Robertson","year":"2001","unstructured":"Robertson D, Flattem N, Tellioglu T, Carson R, Garland E, Shannon JR et al (2001) Familial orthostatic tachycardia due to norepinephrine transporter deficiency. Ann N Y Acad Sci. 940:527\u2013543","journal-title":"Ann N Y Acad Sci."},{"issue":"1","key":"8755_CR47","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/mp.2016.40","volume":"22","author":"FZ Marques","year":"2017","unstructured":"Marques FZ, Eikelis N, Bayles RG, Lambert EA, Straznicky NE, Hering D et al (2017) A polymorphism in the norepinephrine transporter gene is associated with affective and cardiovascular disease through a microRNA mechanism. Mol Psychiatry. 22(1):134\u2013141","journal-title":"Mol Psychiatry."},{"issue":"8","key":"8755_CR48","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1161\/ATVBAHA.111.244343","volume":"32","author":"R Bayles","year":"2012","unstructured":"Bayles R, Harikrishnan KN, Lambert E, Baker EK, Agrotis A, Guo L et al (2012) Epigenetic modification of the norepinephrine transporter gene in postural tachycardia syndrome. Arterioscler Thromb Vasc Biol. 32(8):1910\u20131916","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"2","key":"8755_CR49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1161\/CIRCEP.107.750471","volume":"1","author":"E Lambert","year":"2008","unstructured":"Lambert E, Eikelis N, Esler M, Dawood T, Schlaich M, Bayles R et al (2008) Altered sympathetic nervous reactivity and norepinephrine transporter expression in patients with postural tachycardia syndrome. Circ Arrhythm Electrophysiol. 1(2):103\u2013109","journal-title":"Circ Arrhythm Electrophysiol."},{"issue":"3","key":"8755_CR50","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1161\/hc0302.102597","volume":"105","author":"C Schroeder","year":"2002","unstructured":"Schroeder C, Tank J, Boschmann M, Diedrich A, Sharma AM, Biaggioni I et al (2002) Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance. Circulation. 105(3):347\u2013353","journal-title":"Circulation."},{"issue":"5","key":"8755_CR51","doi-asserted-by":"publisher","first-page":"e000395","DOI":"10.1161\/JAHA.113.000395","volume":"2","author":"EA Green","year":"2013","unstructured":"Green EA, Raj V, Shibao CA, Biaggioni I, Black BK, Dupont WD et al (2013) Effects of norepinephrine reuptake inhibition on postural tachycardia syndrome. J Am Heart Assoc. 2(5):e000395","journal-title":"J Am Heart Assoc."},{"issue":"13","key":"8755_CR52","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1161\/01.CIR.0000160356.97313.5D","volume":"111","author":"SR Raj","year":"2005","unstructured":"Raj SR, Biaggioni I, Yamhure PC, Black BK, Paranjape SY, Byrne DW et al (2005) Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome. Circulation. 111(13):1574\u20131582","journal-title":"Circulation."},{"issue":"14","key":"8755_CR53","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1212\/WNL.0b013e31826d5f95","volume":"79","author":"A Parsaik","year":"2012","unstructured":"Parsaik A, Allison TG, Singer W, Sletten DM, Joyner MJ, Benarroch EE et al (2012) Deconditioning in patients with orthostatic intolerance. Neurology. 79(14):1435\u20131439","journal-title":"Neurology."},{"key":"8755_CR54","doi-asserted-by":"crossref","unstructured":"Nagiub M, Moskowitz W, Fortunato J (2018) Systematic literature review of pathophysiology of postural orthostatic tachycardia syndrome (angiotensin II receptor subtypes imbalance theory). Prog Pediatr Cardiol","DOI":"10.1016\/j.ppedcard.2018.01.003"},{"issue":"11","key":"8755_CR55","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.4065\/74.11.1106","volume":"74","author":"P Sandroni","year":"1999","unstructured":"Sandroni P, Opfer-Gehrking TL, McPhee BR, Low PA (1999) Postural tachycardia syndrome: clinical features and follow-up study. Mayo Clin Proc. 74(11):1106\u20131110","journal-title":"Mayo Clin Proc."},{"issue":"18","key":"8755_CR56","first-page":"30015","volume":"18","author":"B Goodman","year":"2018","unstructured":"Goodman B (2018) Evaluation of postural tachycardia syndrome (POTS). Auton Neurosci 18(18):30015\u201330018","journal-title":"Auton Neurosci"},{"issue":"2","key":"8755_CR57","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.autneu.2013.02.021","volume":"177","author":"K Bagai","year":"2013","unstructured":"Bagai K, Wakwe CI, Malow B, Black BK, Biaggioni I, Paranjape SY et al (2013) Estimation of sleep disturbances using wrist actigraphy in patients with postural tachycardia syndrome. Auton Neurosci. 177(2):260\u2013265","journal-title":"Auton Neurosci."},{"issue":"981","key":"8755_CR58","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1136\/pgmj.2006.055046","volume":"83","author":"G Agarwal","year":"2007","unstructured":"Agarwal G, Ritch S (2007) Postural orthostatic tachycardia syndrome. Postgrad Med J. 83(981):478\u2013480","journal-title":"Postgrad Med J."},{"issue":"2","key":"8755_CR59","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1161\/HYPERTENSIONAHA.111.172262","volume":"58","author":"Q Fu","year":"2011","unstructured":"Fu Q, Vangundy TB, Shibata S, Auchus RJ, Williams GH, Levine BD (2011) Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome. Hypertension. 58(2):167\u2013175","journal-title":"Hypertension."},{"issue":"25","key":"8755_CR60","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1016\/j.jacc.2010.02.043","volume":"55","author":"Q Fu","year":"2010","unstructured":"Fu Q, Vangundy TB, Galbreath MM, Shibata S, Jain M, Hastings JL et al (2010) Cardiac origins of the postural orthostatic tachycardia syndrome. J Am Coll Cardiol. 55(25):2858\u20132868","journal-title":"J Am Coll Cardiol."},{"issue":"3","key":"8755_CR61","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1161\/01.HYP.0000156540.25707.af","volume":"45","author":"R Winker","year":"2005","unstructured":"Winker R, Barth A, Bidmon D, Ponocny I, Weber M, Mayr O et al (2005) Endurance exercise training in orthostatic intolerance: a randomized, controlled trial. Hypertension. 45(3):391\u2013398","journal-title":"Hypertension."},{"issue":"3","key":"8755_CR62","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10286-011-0155-1","volume":"22","author":"A Sousa","year":"2012","unstructured":"Sousa A, Lebreiro A, Freitas J, Maciel MJ (2012) Long-term follow-up of patients with postural tachycardia syndrome. Clin Auton Res. 22(3):151\u2013153","journal-title":"Clin Auton Res."},{"issue":"2","key":"8755_CR63","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1540-8159.2008.02207.x","volume":"32","author":"CC Lai","year":"2009","unstructured":"Lai CC, Fischer PR, Brands CK, Fisher JL, Porter CJ, Driscoll SW et al (2009) Outcomes in adolescents with postural orthostatic tachycardia syndrome treated with midodrine and beta-blockers. Pacing Clin Electrophysiol. 32(2):234\u2013238","journal-title":"Pacing Clin Electrophysiol."},{"issue":"8","key":"8755_CR64","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.mayocp.2012.02.020","volume":"87","author":"K Kimpinski","year":"2012","unstructured":"Kimpinski K, Figueroa JJ, Singer W, Sletten DM, Iodice V, Sandroni P et al (2012) A prospective, 1-year follow-up study of postural tachycardia syndrome. Mayo Clin Proc. 87(8):746\u2013752","journal-title":"Mayo Clin Proc."},{"key":"8755_CR65","unstructured":"Afrin LB (2013) Presentation, diagnosis, and management of mast cell activation syndrome. In: Murray DB (ed) Mast cells: phenotypic features, biological functions and role in immunity. Nova Science Publishers, Inc, pp 155\u2013232"},{"issue":"6","key":"8755_CR66","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/00005792-198811000-00001","volume":"67","author":"WD Travis","year":"1988","unstructured":"Travis WD, Li CY, Bergstralh EJ, Yam LT, Swee RG (1988) Systemic mast cell disease. Analysis of 58 cases and literature review. Medicine (Baltimore) 67(6):345\u2013368","journal-title":"Medicine (Baltimore)"},{"issue":"3 Suppl","key":"8755_CR67","first-page":"65S","volume":"96","author":"DD Metcalfe","year":"1991","unstructured":"Metcalfe DD (1991) Classification and diagnosis of mastocytosis: current status. J Invest Dermatol. 96(3 Suppl):65S","journal-title":"J Invest Dermatol."},{"issue":"3 Suppl","key":"8755_CR68","first-page":"65S","volume":"96","author":"LJ Roberts","year":"1991","unstructured":"Roberts LJ, Oates JA (1991) Biochemical diagnosis of systemic mast cell disorders. J Invest Dermatol. 96(3 Suppl):65S","journal-title":"J Invest Dermatol."},{"issue":"6","key":"8755_CR69","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","volume":"37","author":"P Valent","year":"2007","unstructured":"Valent P, Akin C, Escribano L, F\u00f6dinger M, Hartmann K, Brockow K et al (2007) Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest. 37(6):435\u2013453","journal-title":"Eur J Clin Invest."},{"issue":"7","key":"8755_CR70","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","volume":"25","author":"P Valent","year":"2001","unstructured":"Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB et al (2001) Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 25(7):603\u2013625","journal-title":"Leuk Res."},{"issue":"2","key":"8755_CR71","first-page":"158","volume":"142","author":"K Sonneck","year":"2007","unstructured":"Sonneck K, Florian S, M\u00fcllauer L, Wimazal F, F\u00f6dinger M, Sperr WR et al (2007) Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: monoclonal mast cell activation syndrome. IAA. 142(2):158\u2013164","journal-title":"IAA."},{"issue":"6","key":"8755_CR72","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.jaci.2010.08.035","volume":"126","author":"C Akin","year":"2010","unstructured":"Akin C, Valent P, Metcalfe DD (2010) Mast cell activation syndrome: proposed diagnostic criteria: towards a global classification for mast cell disorders. J Allergy Clin Immunol. 126(6):1099\u20131104","journal-title":"J Allergy Clin Immunol."},{"issue":"3","key":"8755_CR73","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000328760","volume":"157","author":"P Valent","year":"2012","unstructured":"Valent P, Akin C, Arock M, Brockow K, Butterfield JH, Carter MC et al (2012) Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol 157(3):215","journal-title":"Int Arch Allergy Immunol"},{"issue":"11","key":"8755_CR74","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","volume":"129","author":"P Valent","year":"2017","unstructured":"Valent P, Akin C, Metcalfe DD (2017) Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood. 129(11):1420\u20131427","journal-title":"Blood."},{"issue":"2","key":"8755_CR75","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.iac.2014.01.003","volume":"34","author":"K Brockow","year":"2014","unstructured":"Brockow K (2014) Epidemiology, prognosis, and risk factors in mastocytosis. Immunol Allergy Clin N Am. 34(2):283\u2013295","journal-title":"Immunol Allergy Clin N Am."},{"issue":"3 Suppl","key":"8755_CR76","first-page":"65S","volume":"96","author":"BV Kettelhut","year":"1991","unstructured":"Kettelhut BV, Metcalfe DD (1991) Pediatric mastocytosis. J Invest Dermatol. 96(3 Suppl):65S","journal-title":"J Invest Dermatol."},{"issue":"6","key":"8755_CR77","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1172\/JCI118337","volume":"96","author":"LB Schwartz","year":"1995","unstructured":"Schwartz LB, Sakai K, Bradford TR, Ren S, Zweiman B, Worobec AS et al (1995) The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest. 96(6):2702\u20132710","journal-title":"J Clin Invest."},{"issue":"1","key":"8755_CR78","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.molimm.2014.01.018","volume":"63","author":"JS Dahlin","year":"2015","unstructured":"Dahlin JS, Hallgren J (2015) Mast cell progenitors: origin, development and migration to tissues. Mol Immunol. 63(1):9\u201317","journal-title":"Mol Immunol."},{"issue":"10","key":"8755_CR79","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1369\/0022155414545334","volume":"62","author":"EZ Silva","year":"2014","unstructured":"Silva EZ (2014) Marcelino da, Jamur MC, Oliver C. Mast cell function: a new vision of an old cell. J Histochem Cytochem. 62(10):698\u2013738","journal-title":"J Histochem Cytochem."},{"issue":"2","key":"8755_CR80","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jaci.2017.06.007","volume":"140","author":"C Akin","year":"2017","unstructured":"Akin C (2017) Mast cell activation syndromes. J Allergy Clin Immunol. 140(2):349\u2013355","journal-title":"J Allergy Clin Immunol."},{"issue":"1","key":"8755_CR81","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1756-8722-4-10","volume":"4","author":"GJ Molderings","year":"2011","unstructured":"Molderings GJ, Brettner S, Homann J, Afrin LB (2011) Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. J Hematol Oncol 4(1):10","journal-title":"J Hematol Oncol"},{"key":"8755_CR82","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/all.12126","volume":"68","author":"P Valent","year":"2013","unstructured":"Valent P (2013) Mast cell activation syndromes: definition and classification. Eur J Allergy Clin Immunol 68:417\u2013424","journal-title":"Eur J Allergy Clin Immunol"},{"issue":"1","key":"8755_CR83","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11882-012-0326-8","volume":"13","author":"J Cardet","year":"2013","unstructured":"Cardet J, Castells M, Hamilton M (2013) Immunology and clinical manifestations of non-clonal mast cell activation syndrome. Curr Allergy Asthma Rep. 13(1):10\u201318","journal-title":"Curr Allergy Asthma Rep."},{"issue":"1","key":"8755_CR84","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/ajmg.c.31555","volume":"175C","author":"S Seneviratne","year":"2017","unstructured":"Seneviratne S, Maitland A, Afrin L (2017) Mast cell disorders in Ehlers\u2013Danlos syndrome. Am J Med Genet C Semin Med Genet. 175C(1):226\u2013236","journal-title":"Am J Med Genet C Semin Med Genet."},{"key":"8755_CR85","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00210-016-1247-1","volume":"389","author":"GJ Molderings","year":"2016","unstructured":"Molderings GJ, Haenisch B, Brettner S, Homann J, Menzen M, Dumoulin FL et al (2016) Pharmacological treatment options for mast cell activation disease. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 389:671","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"3","key":"8755_CR86","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jaip.2014.03.009","volume":"2","author":"KC Sokol","year":"2014","unstructured":"Sokol KC, Ghazi A, Kelly BC, Grant JA (2014) Omalizumab as a desensitizing agent and treatment in mastocytosis: a review of the literature and case report. J Allergy Clin Immunol Pract. 2(3):266\u2013270","journal-title":"J Allergy Clin Immunol Pract."},{"issue":"3 Pt 1","key":"8755_CR87","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/0091-6749(88)90015-2","volume":"82","author":"MM Garriga","year":"1988","unstructured":"Garriga MM, Friedman MM, Metcalfe DD (1988) A survey of the number and distribution of mast cells in the skin of patients with mast cell disorders. J Allergy Clin Immunol. 82(3 Pt 1):425\u2013432","journal-title":"J Allergy Clin Immunol."},{"issue":"7","key":"8755_CR88","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1182\/blood-2006-06-028100","volume":"110","author":"C Akin","year":"2007","unstructured":"Akin C, Scott LM, Kocabas CN, Kushnir-Sukhov N, Brittain E, Noel P et al (2007) Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with \u201cidiopathic\u201d anaphylaxis. Blood. 110(7):2331\u20132333","journal-title":"Blood."},{"issue":"3","key":"8755_CR89","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/labmed\/lmx026","volume":"48","author":"JM Astle","year":"2017","unstructured":"Astle JM, Rose MG, Racke FK, Tormey CA, Siddon AJ (2017) R634W KIT mutation in an adult with systemic mastocytosis. Lab Med. 48(3):253\u2013257","journal-title":"Lab Med."},{"issue":"2","key":"8755_CR90","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/pde.12381","volume":"32","author":"WL Pollard","year":"2015","unstructured":"Pollard WL, Beachkofsky TM, Kobayashi TT (2015) Novel R634W c-kit mutation identified in familial mastocytosis. Pediatr Dermatol. 32(2):267\u2013270","journal-title":"Pediatr Dermatol."},{"issue":"8","key":"8755_CR91","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1182\/blood-2003-11-3816","volume":"103","author":"C Akin","year":"2004","unstructured":"Akin C, Fumo G, Yavuz AS, Lipsky PE, Neckers L, Metcalfe DD (2004) A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib. Blood. 103(8):3222\u20133225","journal-title":"Blood."},{"issue":"3","key":"8755_CR92","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S0002-9440(10)63870-9","volume":"162","author":"K Sotlar","year":"2003","unstructured":"Sotlar K, Escribano L, Landt O, M\u00f6hrle S, Herrero S, Torrelo A et al (2003) One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes. Am J Pathol. 162(3):737\u2013746","journal-title":"Am J Pathol."},{"issue":"7","key":"8755_CR93","first-page":"1777","volume":"27","author":"R Grahame","year":"2000","unstructured":"Grahame R, Bird HA, Child A (2000) The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). J Rheumatol. 27(7):1777\u20131779","journal-title":"J Rheumatol."},{"issue":"11","key":"8755_CR94","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1002\/ajmg.a.33070","volume":"149A","author":"BT Tinkle","year":"2009","unstructured":"Tinkle BT, Bird HA, Grahame R, Lavallee M, Levy HP, Sillence D (2009) The lack of clinical distinction between the hypermobility type of Ehlers-Danlos syndrome and the joint hypermobility syndrome (a.k.a. hypermobility syndrome). Am J Med Genet A. 149A(11):2368\u20132370","journal-title":"Am J Med Genet A."},{"issue":"12","key":"8755_CR95","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1002\/ajmg.a.36805","volume":"164","author":"M Castori","year":"2014","unstructured":"Castori M, Dordoni C, Valiante M, Sperduti I, Ritelli M, Morlino S et al (2014) Nosology and inheritance pattern(s) of joint hypermobility syndrome and Ehlers-Danlos syndrome, hypermobility type: a study of intrafamilial and interfamilial variability in 23 Italian pedigrees. Am J Med Genet A. 164(12):3010\u20133020","journal-title":"Am J Med Genet A."},{"issue":"4","key":"8755_CR96","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/S0022-3476(99)70173-3","volume":"135","author":"P Rowe","year":"1999","unstructured":"Rowe P, Barron D, Calkins H, Maumenee I, Tong PY, Geraghty MT (1999) Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome. J Pediatr. 135(4):494\u2013499","journal-title":"J Pediatr."},{"issue":"2","key":"8755_CR97","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s11999-014-3898-x","volume":"473","author":"E Grigoriou","year":"2015","unstructured":"Grigoriou E, Boris JR, Dormans JP (2015) Postural Orthostatic Tachycardia Syndrome (POTS): association with Ehlers-Danlos syndrome and orthopaedic considerations. Clin Orthop Relat Res 473(2):722","journal-title":"Clin Orthop Relat Res"},{"key":"8755_CR98","doi-asserted-by":"crossref","unstructured":"Wallman D, Weinberg J, Hohler AD. Ehlers\u2013Danlos syndrome and postural tachycardia syndrome: a relationship study. J Neurol Sci. 2014;340(1\u20132):99\u2013102.","DOI":"10.1016\/j.jns.2014.03.002"},{"issue":"1","key":"8755_CR99","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0002-9343(03)00235-3","volume":"115","author":"Y Gazit","year":"2003","unstructured":"Gazit Y, Nahir AM, Grahame R, Jacob G (2003) Dysautonomia in the joint hypermobility syndrome. Am J Med. 115(1):33\u201340","journal-title":"Am J Med."},{"key":"8755_CR100","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.autneu.2017.10.001","volume":"208","author":"M Miglis","year":"2017","unstructured":"Miglis M, Schultz B, Muppidi S (2017) Postural tachycardia in hypermobile Ehlers-Danlos syndrome: a distinct subtype? Auton Neurosci. 208:146\u2013149","journal-title":"Auton Neurosci."},{"issue":"3","key":"8755_CR101","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1161\/01.HYP.0000158259.68614.40","volume":"45","author":"C Shibao","year":"2005","unstructured":"Shibao C, Jackson Roberts IIL, Raj S, Black B, Harris P, Biaggioni I (2005) Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders. Hypertension. 45(3):385\u2013390","journal-title":"Hypertension."},{"issue":"17","key":"8755_CR102","first-page":"30338","volume":"S1566\u20130702","author":"T Doherty","year":"2018","unstructured":"Doherty T, White A (2018) Postural orthostatic tachycardia syndrome and the potential role of mast cell activation. Auton Neurosci. S1566\u20130702(17):30338\u201330337","journal-title":"Auton Neurosci."},{"issue":"2","key":"8755_CR103","doi-asserted-by":"publisher","first-page":"AB65","DOI":"10.1016\/j.jaci.2014.12.1146","volume":"135","author":"I Cheung","year":"2015","unstructured":"Cheung I, Vadas P (2015) A new disease cluster: mast cell activation syndrome, postural orthostatic tachycardia syndrome, and Ehlers-Danlos syndrome. J Allergy Clin Immunol. 135(2):AB65","journal-title":"J Allergy Clin Immunol."},{"issue":"1","key":"8755_CR104","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/ajmg.a.38518","volume":"176","author":"J Vengoechea","year":"2018","unstructured":"Vengoechea J (2018) In reply to \u201cMast Cell Disorders in Ehlers-Danlos Syndrome\u201d. Am J Med Genet. 176(1):250","journal-title":"Am J Med Genet."},{"key":"8755_CR105","doi-asserted-by":"crossref","unstructured":"Beighton P, Grahame R, Bird H (2012) The molecular basis of joint hypermobility. In: Hypermobility of joints. Springer, pp 27\u201347","DOI":"10.1007\/978-1-84882-085-2_3"},{"issue":"9","key":"8755_CR106","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1002\/art.20488","volume":"50","author":"MC Zweers","year":"2004","unstructured":"Zweers MC, Hakim AJ, Grahame R, Schalkwijk J (2004) Joint hypermobility syndromes: the pathophysiologic role of tenascin-X gene defects. Arthritis Rheum. 50(9):2742\u20132749","journal-title":"Arthritis Rheum."},{"issue":"3","key":"8755_CR107","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1152\/ajpendo.00056.2013","volume":"306","author":"S Hirai","year":"2014","unstructured":"Hirai S, Ohyane C, Kim Y, Lin S, Goto T, Takahashi N et al (2014) Involvement of mast cells in adipose tissue fibrosis. Am J Physiol Endocrinol Metab. 306(3):247","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"8755_CR108","first-page":"w13999","volume":"144","author":"T H\u00fcgle","year":"2014","unstructured":"H\u00fcgle T (2014) Beyond allergy: the role of mast cells in fibrosis. Swiss Med Wkly. 144:w13999","journal-title":"Swiss Med Wkly."},{"issue":"1","key":"8755_CR109","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/imr.12626","volume":"282","author":"P Bradding","year":"2018","unstructured":"Bradding P, Pejler G (2018) The controversial role of mast cells in fibrosis. Immunol Rev. 282(1):198\u2013231","journal-title":"Immunol Rev."},{"issue":"6","key":"8755_CR110","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1172\/JCI119290","volume":"99","author":"JA Cairns","year":"1997","unstructured":"Cairns JA, Walls AF (1997) Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest. 99(6):1313\u20131321","journal-title":"J Clin Invest."},{"issue":"2","key":"8755_CR111","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1046\/j.1365-2222.2002.01293.x","volume":"32","author":"E Garbuzenko","year":"2002","unstructured":"Garbuzenko E, Nagler A, Pickholtz D, Gillery P, Reich R, Maquart F et al (2002) Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis. Clin Exp Allergy. 32(2):237\u2013246","journal-title":"Clin Exp Allergy."},{"issue":"7","key":"8755_CR112","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1136\/thx.43.7.552","volume":"43","author":"J Manel","year":"1988","unstructured":"Manel J, Befus D, Newhouse M, Bienenstock J, Gauldie J, McMaster U (1988) Effect of histamine on proliferation of normal human adult lung fibroblasts. Thorax. 43(7):552\u2013558","journal-title":"Thorax."},{"issue":"1","key":"8755_CR113","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/BF00406482","volume":"277","author":"A Hatamochi","year":"1985","unstructured":"Hatamochi A, Fujiwara K, Ueki H (1985) Effects of histamine on collagen synthesis by cultured fibroblasts derived from guinea pig skin. Arch Dermatol Res. 277(1):60\u201364","journal-title":"Arch Dermatol Res."},{"issue":"3","key":"8755_CR114","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/jcp.1040930310","volume":"93","author":"JD Russel","year":"1977","unstructured":"Russel JD, Russell SB, Trupin KM (1977) The effect of histamine on the growth of cultured fibroblasts isolated from normal and keloid tissue. J Cell Physiol. 93(3):389\u2013393","journal-title":"J Cell Physiol."},{"issue":"1 Pt 2","key":"8755_CR115","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1067\/mai.2000.106058","volume":"106","author":"M Abe","year":"2000","unstructured":"Abe M, Kurosawa M, Ishikawa O, Miyachi Y (2000) Effect of mast cell-derived mediators and mast cell-related neutral proteases on human dermal fibroblast proliferation and type I collagen production. J Allergy Clin Immunol. 106(1 Pt 2):78","journal-title":"J Allergy Clin Immunol."},{"issue":"1","key":"8755_CR116","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.semarthrit.2013.12.006","volume":"44","author":"I De Wandele","year":"2014","unstructured":"De Wandele I, Rombaut L, Leybaert L, Van de Borne P, De Backer T, Malfait F et al (2014) Dysautonomia and its underlying mechanisms in the hypermobility type of Ehlers\u2013Danlos syndrome. Semin Arthritis Rheum. 44(1):93\u2013100","journal-title":"Semin Arthritis Rheum."},{"issue":"3","key":"8755_CR117","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.iac.2018.04.004","volume":"38","author":"R Bonamichi-Santos","year":"2018","unstructured":"Bonamichi-Santos R, Yoshimi-Kanamori K, Giavina-Bianchi P, Aun MV (2018) Association of postural tachycardia syndrome and Ehlers-Danlos syndrome with mast cell activation disorders. Immunol Allergy Clin N Am 38(3):497\u2013504","journal-title":"Immunol Allergy Clin N Am"},{"issue":"6","key":"8755_CR118","doi-asserted-by":"publisher","first-page":"1450.e3","DOI":"10.1016\/j.jaci.2014.06.007","volume":"134","author":"V Sabato","year":"2014","unstructured":"Sabato V, Van De Vijver E, Hagendorens M, Vrelust I, Reyniers E, Fransen E et al (2014) Familial hypertryptasemia with associated mast cell activation syndrome. J Allergy Clin Immunol 134(6):1450.e3","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"8755_CR119","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.jaci.2013.11.039","volume":"133","author":"JJ Lyons","year":"2014","unstructured":"Lyons JJ, Sun G, Stone KD, Nelson C, Wisch L, O\u2019Brien M et al (2014) Mendelian inheritance of elevated serum tryptase associated with atopy and connective tissue abnormalities. J Allergy Clin Immunol. 133(5):1471\u20131474","journal-title":"J Allergy Clin Immunol."},{"issue":"12","key":"8755_CR120","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/ng.3696","volume":"48","author":"JJ Lyons","year":"2016","unstructured":"Lyons JJ, Yu X, Hughes JD, Le QT, Jamil A, Bai Y et al (2016) Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number. Nat Genet. 48(12):1564\u20131569","journal-title":"Nat Genet."},{"key":"8755_CR121","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.imlet.2016.07.003","volume":"178","author":"C Cardamone","year":"2016","unstructured":"Cardamone C, Parente R, Feo GD, Triggiani M (2016) Mast cells as effector cells of innate immunity and regulators of adaptive immunity. Immunol Lett 178:10\u201314","journal-title":"Immunol Lett"},{"issue":"7","key":"8755_CR122","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/eji.201040559","volume":"40","author":"SJ Galli","year":"2010","unstructured":"Galli SJ, Tsai M (2010) Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity. Eur J Immunol. 40(7):1843\u20131851","journal-title":"Eur J Immunol."},{"issue":"4","key":"8755_CR123","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/cea.12509","volume":"45","author":"J Suurmond","year":"2015","unstructured":"Suurmond J, Dorj\u00e9e AL, Knol EF, Huizinga TWJ, Toes REM (2015) Differential TLR-induced cytokine production by human mast cells is amplified by Fc\u025bRI triggering. Clin Exp Allergy. 45(4):788\u2013796","journal-title":"Clin Exp Allergy."},{"issue":"1","key":"8755_CR124","first-page":"1","volume":"33","author":"CE Gallenga","year":"2019","unstructured":"Gallenga CE, Pandolfi F, Caraffa A, Kritas SK, Ronconi G, Toniato E et al (2019) Interleukin-1 family cytokines and mast cells: activation and inhibition. J Biol Regul Homeost Agents 33(1):1\u20136","journal-title":"J Biol Regul Homeost Agents"},{"key":"8755_CR125","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejphar.2015.07.017","volume":"778","author":"Y Yu","year":"2016","unstructured":"Yu Y, Blokhuis BR, Garssen J, Redegeld FA (2016) Non-IgE mediated mast cell activation. Eur J Pharmacol 778:33\u201343","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"8755_CR126","doi-asserted-by":"publisher","first-page":"362","DOI":"10.5858\/2006-130-362-MEIMMC","volume":"130","author":"S Jakate","year":"2006","unstructured":"Jakate S, Demeo M, John R, Tobin M, Keshavarzian A (2006) Mastocytic enterocolitis: increased mucosal mast cells in chronic intractable diarrhea. Arch Pathol Lab Med. 130(3):362\u2013367","journal-title":"Arch Pathol Lab Med."},{"issue":"11","key":"8755_CR127","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1097\/PAS.0b013e318078ce7a","volume":"31","author":"HP Hahn","year":"2007","unstructured":"Hahn HP, Hornick JL (2007) Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis. Am J Surg Pathol. 31(11):1669\u20131676","journal-title":"Am J Surg Pathol."},{"issue":"2","key":"8755_CR128","doi-asserted-by":"publisher","first-page":"225","DOI":"10.5858\/arpa.2013-0594-OA","volume":"139","author":"A Sethi","year":"2015","unstructured":"Sethi A, Jain D, Roland BC, Kinzel J, Gibson J, Schrader R et al (2015) Performing colonic mast cell counts in patients with chronic diarrhea of unknown etiology has limited diagnostic use. Arch Pathol Lab Med. 139(2):225\u2013232","journal-title":"Arch Pathol Lab Med."},{"issue":"6","key":"8755_CR129","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1097\/PAS.0000000000000190","volume":"38","author":"LA Doyle","year":"2014","unstructured":"Doyle LA, Sepehr GJ, Hamilton MJ, Akin C, Castells MC, Hornick JL (2014) A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients. Am J Surg Pathol. 38(6):832\u2013843","journal-title":"Am J Surg Pathol."},{"key":"8755_CR130","doi-asserted-by":"crossref","unstructured":"Obrenovich MEM (2018) Leaky gut, leaky brain? Microorganisms 6(4)","DOI":"10.3390\/microorganisms6040107"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-019-08755-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-019-08755-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-019-08755-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T13:16:04Z","timestamp":1714655764000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-019-08755-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,2]]},"references-count":130,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["8755"],"URL":"https:\/\/doi.org\/10.1007\/s12016-019-08755-8","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,2]]},"assertion":[{"value":"2 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}